Location History:
- Greater London, GB (2022)
- London, GB (2022)
- London Greater London, GB (2024)
Company Filing History:
Years Active: 2022-2024
Title: Innovations of Wai Lui in Cancer Treatment
Introduction
Wai Lui is an accomplished inventor based in Greater London, GB. He has made significant contributions to the field of cancer research, holding a total of 3 patents. His work focuses on developing methods to enhance the efficacy of anti-cancer agents.
Latest Patents
One of Wai Lui's latest patents is an assay designed to identify anti-cancer agents. This in vitro method aims to identify an anti-cancer agent whose therapeutic efficacy is enhanced when administered alongside a second agent that increases the expression of OPRK1 and/or BAD. The findings indicate that agents boosting the expression of the opioid receptor kappa 1 (OPRK1) can significantly enhance the cytotoxicity of chemotherapeutic agents across multiple cancer cell lines. Notably, the effect is dose-dependent, meaning that the greater the induced expression of OPRK1, the higher the cytotoxicity of the chemotherapeutic agent. Importantly, the increase in overall cytotoxicity is independent of the cytotoxicity of the agent that increases the expression of OPRK1, which itself exhibits minimal or no cytotoxic effect.
Career Highlights
Wai Lui is currently associated with Ldn Pharma Limited, where he continues to innovate in the field of cancer treatment. His work has garnered attention for its potential to improve therapeutic outcomes for cancer patients.
Collaborations
Wai Lui collaborates with notable professionals in his field, including Angus Dalgleish, enhancing the impact of his research through shared expertise.
Conclusion
Wai Lui's innovative approaches to cancer treatment demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of the mechanisms involved in cancer therapy, paving the way for future breakthroughs in the field.